Belgian consensus guideline on the management of hemorrhoidal disease.

bleeding external hemorrhoids hemorrhoidal disease internal hemorrhoids prolapse thrombosis

Journal

Acta gastro-enterologica Belgica
ISSN: 1784-3227
Titre abrégé: Acta Gastroenterol Belg
Pays: Belgium
ID NLM: 0414075

Informations de publication

Date de publication:
Historique:
entrez: 28 2 2021
pubmed: 1 3 2021
medline: 3 3 2021
Statut: ppublish

Résumé

Hemorrhoidal disease is a common problem that arises when hemorrhoidal structures become engorged and/or prolapse through the anal canal. Both conservative and invasive treatment options are diverse and guidance to their implementation is lacking. A Delphi consensus process was used to review current literature and draft relevant statements. These were reconciliated until sufficient agreement was reached. The grade of evidence was determined. These guidelines were based on the published literature up to June 2020. Hemorrhoids are normal structures within the anorectal region. When they become engorged or slide down the anal canal, symptoms can arise. Every treatment for symptomatic hemorrhoids should be tailored to patient profile and expectations. For low-grade hemorrhoids, conservative treatment should consist of fiber supplements and can include a short course of venotropics. Instrumental treatment can be added case by case : infrared coagulation or rubber band ligation when prolapse is more prominent. For prolapsing hemorrhoids, surgery can be indicated for refractory cases. Conventional hemorrhoidectomy is the most efficacious intervention for all grades of hemorrhoids and is the only choice for non-reducible prolapsing hemorrhoids. The current guidelines for the management of hemorrhoidal disease include recommendations for the clinical evaluation of hemorrhoidal disorders, and their conservative, instrumental and surgical management.

Identifiants

pubmed: 33639701
doi: 10.51821/84.1.497

Types de publication

Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

101-120

Informations de copyright

© Acta Gastro-Enterologica Belgica.

Auteurs

H De Schepper (H)

Department of Gastroenterology and Hepatology, University Hospital Antwerp, Belgium.

G Coremans (G)

Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.

M A Denis (MA)

Department of Gastroenterology and Hepatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

P Dewint (P)

Department of Gastroenterology and Hepatology, University Hospital Antwerp, Belgium.
Department of Gastroenterology and Hepatology, Maria Middelares Hospital, Ghent, Belgium.

M Duinslaeger (M)

Department of Abdominal Surgery, University Hospital Brussels, Brussels, Belgium.

I Gijsen (I)

Department of Gastroenterology and Hepatology, Noorderhart Hospital, Overpelt, Belgium.

P Haers (P)

Department of Abdominal Surgery, Heilig Hart Leuven Hospital, Leuven, Belgium.

N Komen (N)

Department of Abdominal Surgery, University Hospital Antwerp, Antwerp, Belgium.

C Remue (C)

Colorectal Surgery Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

P Roelandt (P)

Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.

M Somers (M)

Department of Gastroenterology and Hepatology, University Hospital Antwerp, Belgium.

M Surmont (M)

Department of Gastroenterology and Hepatology, University Hospital Brussels, Brussels, Belgium.

D Van de Putte (D)

Department of Abdominal Surgery, University Hospital Ghent, Ghent, Belgium.

S Van den Broeck (S)

Department of Abdominal Surgery, University Hospital Antwerp, Antwerp, Belgium.

C Van Kemseke (C)

Department of Gastroenterology and Hepatology, University Hospital Liege, Liege, Belgium.

D De Looze (D)

Department of Gastroenterology and Hepatology, University Hospital Ghent, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH